Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Kerry Scott
Introduction
Kerry Scott is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on the quantification of specific proteins in biological samples, which is crucial for cancer diagnostics and treatment.
Latest Patents
Kerry Scott holds a patent for "SRM/MRM assays for cancer." This patent outlines methods for quantifying specific proteins directly in biological samples that have been fixed in formalin. The methods involve using SRM/MRM mass spectrometry to detect and quantify proteins such as CD3D, B7H3, B7-2, STAT1, GBP1, GPNMB, CD27, CD3E, and CD8. This innovative approach allows for accurate analysis of chemically preserved biological samples, which is essential for effective cancer research.
Career Highlights
Kerry Scott is associated with Expression Pathology Incorporated, where he applies his expertise in protein quantification. His work has contributed to advancements in cancer diagnostics, making a significant impact in the medical field. His dedication to research and innovation has positioned him as a valuable asset in the scientific community.
Collaborations
Kerry collaborates with talented professionals such as Todd Hembrough and Fabiola Cecchi. These collaborations enhance the research efforts at Expression Pathology Incorporated, fostering an environment of innovation and discovery.
Conclusion
Kerry Scott's contributions to cancer research through his innovative patent demonstrate his commitment to advancing medical science. His work not only aids in the understanding of cancer but also paves the way for improved diagnostic methods.